Biomonitoring of Perfluoroalkyl Acids in Human Urine and Estimates of Biological Half-Life
Biomonitoring of Perfluoroalkyl Acids in Human Urine and Estimates of Biological Half-Life
复制标题
人尿液中全氟烷基酸的生物监测和生物半衰期的估计
DOI:
10.1021/es401905e
复制
发表时间:
2013-09-17
影响因子:
11.4
通讯作者:
Martin, Jonathan W.
中科院分区:
文献类型:
--
作者:
Zhang, Yifeng;Beesoon, Sanjay;Martin, Jonathan W.
Perfluoroalkyl acids (PFAAs) are persistent and bioaccumulative compounds that have been associated with adverse health outcomes. In human blood, PFAAs exist as both linear and branched isomers, yet for most linear homologues, and for all branched isomers, elimination rates are unknown. Paired blood and urine samples (n = 86) were collected from adults in China. They were analyzed by a sensitive isomer-specific method that permitted the detection of many PFAAs in human urine for the first time. For all PFAAs except perfluoroundecanoate (PFUnA), levels in urine correlated positively with levels in blood. Perfluoroalkyl carboxylates (PFCAs) were excreted more efficiently than perfluoroalkane sulfonates (PFSAs) of the same carbon chain-length. In general, shorter PFCAs were excreted more efficiently than longer ones, but for PFSAs, perfluorooctanesulfonate (PFOS, a C8 compound) was excreted more efficiently than perfluorohexanesulfonate (PFHxS, a C6 compound). Among PFOS and perfluorooctanoate (PFOA) isomers, major branched isomers were more efficiently excreted than the corresponding linear isomer. A one-compartment model was used to estimate the biological elimination half lives of PFAAs. Among all PFAAs, the estimated arithmetic mean elimination half-lives ranged from 0.5 +/- 0.1 years (for one branched PFOA isomer, 5m-PF0A) to 90 +/- 11 years (for one branched PFOS isomer, 1m-PFOS). Urinary excretion was the major elimination route for short PFCAs (C